The MHRA acts following discussions with UKVIA and Trading Standards.Read More
The findings come as the FDA prepares to decide on numerous tobacco marketing applications. Read More
The private equity firm’s bid for Vectura remains lower than that made by PMI. Read More
The move underlines the company’s commitment to Canada, says CEORead More
The action affects more than two-thirds of all PMTA products under review. Read More
Some sellers are still holding significant volumes of now-illicit stock. Read More
The studies will help establish a scientific basis for Poda's products as cessation tools.Read More
But they should be combined with other antismoking measures, say researchers. Read More
The acquisition is the company’s third non-tobacco deal in short succession. Read More
The move comes after a counteroffer from Carlyle for the drug delivery solutions provider. Read More
